Member Info for tqhussain

I got this from an employee regarding labskin..

I would be surprised if labskin closes down but with the number of redundancies mentioned it would be difficult to continue under the deepverge umbrella.

I agree with you yankee. I don't have much faith in NB. I decided to give him a call just to get a feel his level of confidence in the proceeding and I might be wrong, nothing sounded positive.

The whole BOD should have been wiped cleaned when the lies surfaced.

I spoke to NB last week. He said the audit was ongoing but the auditor needs more time so, suspension is highly likely.

He did says its unlikely the company will issue a single liner saying it has been suspended. He suggested the rns will give a bit more detail on what's going on.

Time will tell if there is anymore detail!

I would not recommend averaging down here now. There is so much the BOD need to do to prove they have SH interest at heart.

My 60k is worth next to nothing.

I spoke to Nigel and he said the following;

Audit is ongoing but suspension most likely to happen end of the month.

Working capital sounded like a big issue.

There is interest in STC & Labskin but didn't say how far along the talks are.

IMO, overall it sounded like it will take a miracle to keep afloat.

A number of STC and labskin employees have open to work on their LinkedIn profiles.

GB didn’t just ruin our investment but employees livelihood.

I would estimate current cash of around £7m. MC is very low with all the progress made.

I am surprised they are still exploring the sale of one of the businesses.

There's got to be some interest in the "unicorn" STC or "unprecedented demand" labskin.

As set out in the Circular, the Company intends, as soon as practicable, to implement a members voluntary liquidation ("MVL") of the Company in order to distribute the net proceeds of the Sale received by it. However, while these net proceeds are expected to be approximately £500,000, the Company will need to deduct the additional costs and expenses associated with the MVL, as well as the general administrative costs of now having to remain an AIM-quoted company, before the distribution of any residual value can be made to Shareholders.

13MC is nothing, this has more room to grow!

All the talk from GB about STC and Labskin seem like it was bulls... Where is the revenue from the "unprecedented" demand for labskin. STC were going to focus on the north American market but then the STC team is giving away tests in Westfield London.

Sitting on a big loss and contemplating if I should leave the little I have too see what happens next.

Unbelieve bull**** from GB, lost a lot of money here.

Also some news on vortex bio

https://emvcapital.com/vortex-london-cancer-hub-opening/

Interview out

https://globalventuring.com/university/guest/talking-tech-transfer-ilian-iliev/

Thanks for the reply, that makes sense now.

Hi, Was the counter party loan in July 22 RNS'd? I can't find anything out there.

Also, Interested to know why the party decided to go convert the loan at exercisable price of 25p?

"In addition, and further to the announcement made by the Company on 18 January 2023, the Company announces that its short-term loan facility of £2.915 million provided to the Company in July 2022 by a French counterparty has been converted to convertible notes and warrants ("Converted Loan"). The notes will have a minimum conversion price of 25 pence. Warrants to subscribe for 1,250,000 new Ordinary Shares will also be issued on or around 3 March 2023 to the French counterparty with an exercise price of 25 pence per share, exercisable until 3 March 2026."

Some nice large rounded buys over the last week or so. Someone is building a serious stake in the business.

Joined the show this morning. Some interesting projects ongoing and should get good attraction once it gets on AIM.

Nice chunky buys today. GLA

For those new to NSCI, have a look at the portfolio listed on the website. It will give you a good feel for the potential of this company.

https://netscientific.net/portfolio/emv-capital/